Robert Spignesi was named President and Chief Executive Officer of Rapid Micro Biosystems, Inc., effective April 10, 2026. As of November 14, 2026, Rapid Micro Biosystems, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 27, 2026, naming 1 appointment and 1 departure (Form 8-K, March 27, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Rapid Micro Biosystems, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Rapid Micro Biosystems, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-27. It names 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Rapid Micro Biosystems, Inc. files it.
Also on the record for Rapid Micro Biosystems, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G, by Armistice Capital, LLC | 7.29% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Bain Capital Life Sciences Fund, L.P. | 16.76% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Longitude Capital Partners II, LLC | 8.6% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Endeavour Medtech Growth II LP | 5.7% of the class | 5%+ stakes | Source |
| August 19, 2025 | Stake report, Schedule 13D, by SPIGNESI ROBERT G JR | 6.3% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Rapid Micro Biosystems, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Rapid Micro Biosystems, Inc. and the records around it.
Rapid Micro Biosystems, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Endeavour Medtech Growth II LP also filed stake reports on 1 other company: Kestra Medical Technologies, Ltd. (Feb 2026)
- Bain Capital Life Sciences Fund, L.P. also filed stake reports on 2 other companies: Pharvaris N.V. (Feb 2026), X4 PHARMACEUTICALS, INC. (Feb 2026)
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch Rapid Micro Biosystems, Inc.
Get an email when Rapid Micro Biosystems, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Rapid Micro Biosystems, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Rapid Micro Biosystems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Rapid Micro Biosystems, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-27 | Out | Chief Operating Officer | 2026-04-10 | 8-K, 2026-03-27 | |
| 2026-03-27 | In | President and Chief Executive Officer | 2026-04-10 | 8-K, 2026-03-27 |
Why did they leave? What the filings say
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- John Wilson, Chief Operating Officer (filed 2026-03-27):
Mr. Wilson's departure is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Who leads Rapid Micro Biosystems, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President and Chief Executive Officer: Robert Spignesi, appointed, effective 2026-04-10 (filed 2026-03-27).
- Chief Operating Officer: John Wilson, departure reported, effective 2026-04-10 (filed 2026-03-27). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Rapid Micro Biosystems, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Operating Officer at Rapid Micro Biosystems, Inc., with the record behind each one.
Find candidates like Chief Operating Officer at Rapid Micro Biosystems, Inc.Every change, in the filing's words
Departing: John Wilson, Chief Operating Officer, effective 2026-04-10
(b) On March 23, 2026, Mr. John Wilson, Chief Operating Officer of Rapid Micro Biosystems, Inc. (the "Company"), notified the Company of his intention to depart from the Company, effective April 10, 2026, in order to spend more time with his family.
Appointed: Robert Spignesi, President and Chief Executive Officer, effective 2026-04-10
(c) In connection with Mr. Wilson's anticipated departure, Mr. Robert Spignesi, the Company's President and Chief Executive Officer, in addition to his current positions, will assume the role of the Company's principal operating officer, effective April 10, 2026.
- No material plan, contract or arrangement, nor any material amendment thereto, was entered into with Mr. Spignesi in connection with the foregoing event.
- (e) On March 26, 2026, the Company entered into a Consulting Services and Separation Agreement (the "Agreement") with Mr. Wilson.
- The Agreement also includes customary provisions regarding confidentiality, cooperation, non disparagement, return of Company property and other obligations.
Tools for this story
Each opens in a new tab, filled in for Rapid Micro Biosystems, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
